globalhealth

4D)

4D). to make a difference (7, 8, 10). ErbB3/HER3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3/human being epidermal BM 957 receptor 3) can be a… Read More »4D)

Natl

Natl. the need for inner residues as immunodominant epitopes in (12)–mannans also to the viability of the glycoconjugate vaccine made up of a minimal duration… Read More »Natl

T

T. development of neutralizing antibodies in SIVmac-infected animals, thus raising questions concerning the suitability of SIVmac251 as a challenge strain to screen AIDS vaccines that… Read More »T